Atypical Tumor-stromal Fibroblasts in Invasive Ductal Carcinoma of the Breast
Authors:
- Takahiro HasebeTHTakahiro Hasebe
- Motoki IwasakiMIMotoki Iwasaki
- Sadako Akashi-TanakaSASadako Akashi-Tanaka
- Takashi HojoTHTakashi Hojo
- Tatsuhiro ShibataTSTatsuhiro Shibata
- Yuko SasajimaYSYuko Sasajima
- Takayuki KinoshitaTKTakayuki Kinoshita
- Hitoshi TsudaHTHitoshi Tsuda
- 1 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 35 (3) , 325-336
Abstract
Tumor-stromal fibroblasts have recently been reported to play important roles in the tumor progression of cancer in various organs. The purpose of this study was to investigate whether any characteristic histologic features of tumor-stromal fibroblasts could accurately predict the outcome of 1042 patients with invasive ductal carcinoma of the breast. We observed a small number of tumor-stromal fibroblasts with characteristic nuclear features existing inside and outside of fibrotic foci and named them atypical tumor-stromal fibroblasts. We then classified invasive ductal carcinomas into 4 types (1, 2, 3, and 4) according to the absence or presence of fibrotic foci and the absence or presence of atypical tumor-stromal fibroblasts. We then analyzed the outcome predictive powers of these types of invasive ductal carcinomas using multivariate analyses that included well-known clinicopathologic factors. The multivariate analyses showed that type 4 invasive ductal carcinomas with fibrotic foci and atypical tumor-stromal fibroblasts had significantly higher hazard ratios for tumor recurrence and tumor-related death, independent of the nodal status and histologic grade, and the type 2 invasive ductal carcinomas without fibrotic foci but with atypical tumor-stromal fibroblasts had a significant higher hazard ratio for tumor recurrence among patients with invasive ductal carcinoma with nodal metastasis and those with histologic grade 3 disease. The results of this study clearly indicated that the presence of atypical tumor-stromal fibroblasts, especially in fibrotic foci, is significantly associated with tumor recurrence and tumor-related death of patients with invasive ductal carcinoma of the breast.Keywords
This publication has 18 references indexed in Scilit:
- Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breastHuman Pathology, 2010
- p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breastLaboratory Investigation, 2010
- p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapyHuman Pathology, 2010
- Tumor‐host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancerCancer Science, 2009
- p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breastCancer Science, 2009
- Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breastHuman Pathology, 2008
- Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancersEuropean Journal of Cancer, 2005
- Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective studyHuman Pathology, 2005
- Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation studyLaboratory Investigation, 2004
- Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomasNature Genetics, 2002